版本:
中国

BRIEF-Medicinova says FDA granted orphan drug designation to MN-166 for ALS

Oct 11 Medicinova Inc :

* Medicinova announces FDA granted orphan drug designation to MN-166 (ibudilast) for amyotrophic lateral sclerosis

* Medicinova INC -MN-166 demonstrated positive trends in interim efficacy data from mid-study analysis of CHS Neuromuscular/ALS-MDA center study Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐